Literature DB >> 33658982

Integrative Analysis of Proteomics and DNA Methylation in Orbital Fibroblasts From Graves' Ophthalmopathy.

Sita Virakul1, Poorichaya Somparn2,3, Trairak Pisitkun2, Peter J van der Spek4, Virgil A S H Dalm5,6, Dion Paridaens7,8, P Martin van Hagen5,6,7, Nattiya Hirankarn9, Tanapat Palaga1, Willem A Dik5.   

Abstract

Background: Graves' ophthalmopathy (GO) is a frequent extrathyroidal complication of Graves' hyperthyroidism. Orbital fibroblasts contribute to both orbital tissue inflammation and remodeling in GO, and as such are crucial cellular elements in active GO and inactive GO. However, so far it is largely unknown whether GO disease progression is associated with functional reprogramming of the orbital fibroblast effector function. Therefore, the aim of this study was to compare both the proteome and global DNA methylation patterns between orbital fibroblasts isolated from active GO, inactive GO and healthy controls.
Methods: Orbital fibroblasts from inactive GO (n=5), active GO (n=4) and controls (n=5) were cultured and total protein and DNA was isolated. Labelled and fractionated proteins were analyzed with a liquid chromatography tandem-mass spectrometer (LC-MS/MS). Data are available via ProteomeXchange with identifier PXD022257. Furthermore, bisulphite-treated DNA was analyzed for methylation pattern with the Illumina Infinium Human Methylation 450K beadchip. In addition, RNA was isolated from the orbital fibroblasts for real-time quantitative (RQ)-PCR. Network and pathway analyses were performed.
Results: Orbital fibroblasts from active GO displayed overexpression of proteins that are typically involved in inflammation, cellular proliferation, hyaluronan synthesis and adipogenesis, while various proteins associated with extracellular matrix (ECM) biology and fibrotic disease, were typically overexpressed in orbital fibroblasts from inactive GO. Moreover, orbital fibroblasts from active GO displayed hypermethylation of genes that linked to inflammation and hypomethylated genes that linked to adipogenesis and autoimmunity. Further analysis revealed networks that contained molecules to which both hypermethylated and hypomethylated genes were linked, including NF-κB, ERK1/2, Alp, RNA polymerase II, Akt and IFNα. In addition, NF-κB, Akt and IFNα were also identified in networks that were derived from the differentially expressed proteins. Generally, poor correlation between protein expression, DNA methylation and mRNA expression was observed. Conclusions: Both the proteomics and DNA methylation data support that orbital fibroblasts from active GO are involved in inflammation, adipogenesis, and glycosaminoglycan production, while orbital fibroblasts from inactive disease are more skewed towards an active role in extracellular matrix remodeling. This switch in orbital fibroblast effector function may have therapeutic implications and further studies into the underlying mechanism are thus warranted.
Copyright © 2021 Virakul, Somparn, Pisitkun, van der Spek, Dalm, Paridaens, van Hagen, Hirankarn, Palaga and Dik.

Entities:  

Keywords:  DNA methylation; epigenetics; graves’ ophthalmopathy; orbital fibroblast; proteomics

Mesh:

Year:  2021        PMID: 33658982      PMCID: PMC7919747          DOI: 10.3389/fendo.2020.619989

Source DB:  PubMed          Journal:  Front Endocrinol (Lausanne)        ISSN: 1664-2392            Impact factor:   5.555


  81 in total

1.  Type VI Collagen Regulates Dermal Matrix Assembly and Fibroblast Motility.

Authors:  Georgios Theocharidis; Zoe Drymoussi; Alexander P Kao; Asa H Barber; David A Lee; Kristin M Braun; John T Connelly
Journal:  J Invest Dermatol       Date:  2016-01       Impact factor: 8.551

2.  Type I, II, III, IV, V, and VI collagens serve as extracellular ligands for the isoforms of platelet-derived growth factor (AA, BB, and AB).

Authors:  R Somasundaram; D Schuppan
Journal:  J Biol Chem       Date:  1996-10-25       Impact factor: 5.157

Review 3.  The PI3K Pathway in Human Disease.

Authors:  David A Fruman; Honyin Chiu; Benjamin D Hopkins; Shubha Bagrodia; Lewis C Cantley; Robert T Abraham
Journal:  Cell       Date:  2017-08-10       Impact factor: 41.582

4.  Role of miR-146a in the Regulation of Inflammation in an In Vitro Model of Graves' Orbitopathy.

Authors:  Sun Young Jang; Min Kyung Chae; Joon H Lee; Eun Jig Lee; Jin Sook Yoon
Journal:  Invest Ophthalmol Vis Sci       Date:  2016-08-01       Impact factor: 4.799

5.  Collagens in the liver extracellular matrix bind hepatocyte growth factor.

Authors:  D Schuppan; M Schmid; R Somasundaram; R Ackermann; M Ruehl; T Nakamura; E O Riecken
Journal:  Gastroenterology       Date:  1998-01       Impact factor: 22.682

6.  Nuclear factor-kappaB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury.

Authors:  Fiona Oakley; Jelena Mann; Sarah Nailard; David E Smart; Narendra Mungalsingh; Christothea Constandinou; Shakir Ali; Susan J Wilson; Harry Millward-Sadler; John P Iredale; Derek A Mann
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

7.  Platelet-Derived Growth Factor-BB Enhances Adipogenesis in Orbital Fibroblasts.

Authors:  Sita Virakul; Virgil A S H Dalm; Dion Paridaens; Willem A van den Bosch; Monique T Mulder; Nattiya Hirankarn; P Martin van Hagen; Willem A Dik
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-08       Impact factor: 4.799

8.  Rapamycin enhances TNF-α-induced secretion of IL-6 and IL-8 through suppressing PDCD4 degradation in orbital fibroblasts.

Authors:  Won-Mo Lee; Ji-Sun Paik; Won-Kyung Cho; Eun-Hye Oh; Seong-Beom Lee; Suk-Woo Yang
Journal:  Curr Eye Res       Date:  2013-01-02       Impact factor: 2.424

9.  Glucose regulates clathrin adaptors at the trans-Golgi network and endosomes.

Authors:  Quyen L Aoh; Lee M Graves; Mara C Duncan
Journal:  Mol Biol Cell       Date:  2011-08-10       Impact factor: 4.138

10.  MicroRNA-16 inhibits glioma cell growth and invasion through suppression of BCL2 and the nuclear factor-κB1/MMP9 signaling pathway.

Authors:  Tian-Quan Yang; Xiao-Jun Lu; Ting-Feng Wu; Da-Dong Ding; Zhao-Hui Zhao; Gui-Lin Chen; Xue-Shun Xie; Bin Li; Yong-Xin Wei; Ling-Chuan Guo; Yu Zhang; Yu-Lun Huang; You-Xin Zhou; Zi-Wei Du
Journal:  Cancer Sci       Date:  2014-02-11       Impact factor: 6.716

View more
  2 in total

1.  Reactivities of a Prostanoid EP2 Agonist, Omidenepag, Are Useful for Distinguishing between 3D Spheroids of Human Orbital Fibroblasts without or with Graves' Orbitopathy.

Authors:  Yosuke Ida; Hanae Ichioka; Masato Furuhashi; Fumihito Hikage; Megumi Watanabe; Araya Umetsu; Hiroshi Ohguro
Journal:  Cells       Date:  2021-11-16       Impact factor: 6.600

Review 2.  Emerging Insights Into the Role of Epigenetics and Gut Microbiome in the Pathogenesis of Graves' Ophthalmopathy.

Authors:  Yan Wang; Xiao-Min Ma; Xin Wang; Xin Sun; Ling-Jun Wang; Xin-Qi Li; Xiao-Yan Liu; Hong-Song Yu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-05       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.